Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD -0.00

Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) is USD -0.00 for the year ending December 31, 2023, a -156.46% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.01, a 114.46% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD -0.04, a -174.71% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.05, a 21.40% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.04, a 2.29% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email